We are live on ! Find out more
MYGN icon

Myriad Genetics

264 hedge funds and large institutions have $2.22B invested in Myriad Genetics in 2018 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 110 increasing their positions, 74 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 74

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4.23% less ownership

Funds ownership: 106.52%102.29% (-4.2%)

7% less funds holding

Funds holding: 284264 (-20)

36% less capital invested

Capital invested by funds: $3.48B → $2.22B (-$1.26B)

38% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 50

57% less call options, than puts

Call options by funds: $2.43M | Put options by funds: $5.67M

Holders
264
Holders Change
-20
Holders Change %
-7.04%
% of All Funds
5.88%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
31
Increased
110
Reduced
74
Closed
50
Calls
$2.43M
Puts
$5.67M
Net Calls
-$3.23M
Net Calls Change
+$9.06M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$4.79M -$578K -16,074 -9%
TCIM
52
TIAA CREF Investment Management
New York
$4.57M +$790K +21,962 +16%
STB
53
S&T Bank
Pennsylvania
$4.37M -$534K -14,852 -9%
TA
54
Teachers Advisors
New York
$4.3M +$752K +20,916 +16%
MWNA
55
Marshall Wace North America
New York
$4.18M +$5.18M +143,937 New
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$4.18M -$955K -26,551 -16%
Macquarie Group
57
Macquarie Group
Australia
$3.92M -$7.2K -200 -0.1%
Fisher Asset Management
58
Fisher Asset Management
Washington
$3.85M +$149K +4,141 +3%
Swiss National Bank
59
Swiss National Bank
Switzerland
$3.65M +$137K +3,800 +3%
Ohio Public Employees Retirement System (OPERS)
60
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.61M -$837K -23,266 -16%
Federated Hermes
61
Federated Hermes
Pennsylvania
$3.57M -$3.78M -105,192 -46%
ASRS
62
Arizona State Retirement System
Arizona
$3.35M +$441K +12,254 +12%
Comerica Bank
63
Comerica Bank
Texas
$3.27M +$202K +5,614 +5%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$3.19M +$292K +8,114 +8%
Nordea Investment Management
65
Nordea Investment Management
Sweden
$3.1M +$190K +5,274 +5%
American Century Companies
66
American Century Companies
Missouri
$2.81M +$409K +11,372 +13%
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$2.78M +$66.4K +1,847 +2%
KC
68
Kepos Capital
New York
$2.72M +$591K +16,442 +21%
Skandinaviska Enskilda Banken (SEB)
69
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.67M +$309K +8,600 +10%
Canada Life
70
Canada Life
Manitoba, Canada
$2.66M +$358K +9,944 +11%
CAM
71
ClariVest Asset Management
California
$2.62M +$852K +23,687 +36%
SG Americas Securities
72
SG Americas Securities
New York
$2.6M +$3.21M +89,370 New
Axa
73
Axa
France
$2.49M +$1.55M +43,087 +101%
MAP
74
Moody Aldrich Partners
Massachusetts
$2.48M +$3.08M +85,479 New
SEI Investments
75
SEI Investments
Pennsylvania
$2.44M +$1.11M +30,789 +88%

MYGN Hedge Fund Activity: Q4 2018 in Review

264 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q4 2018, worth a combined $2.22B — down 36% from $3.48B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of MYGN and 31 opened new positions — a net loss of 19 holders — while 74 trimmed existing stakes and 110 added.

The largest buyer was Rice Hall James & Associates, opening a new position worth an estimated $28.8M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $83.4M.

  • 264 institutional investors held Myriad Genetics (MYGN) as of Q4 2018, down from 284 in Q3 2018.
  • Funds reported $2.22B of Myriad Genetics stock for Q4 2018, down 36% quarter-over-quarter.
  • 31 funds opened new Myriad Genetics positions in Q4 2018 and 50 closed out, a net change of -19 holders.
  • The largest Myriad Genetics buyer in Q4 2018 was Rice Hall James & Associates, an estimated $28.8M added.
  • The largest Myriad Genetics seller in Q4 2018 was Thrivent Financial for Lutherans, an estimated $83.4M sold.

Based on aggregated 13F filings for Q4 2018.